Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000676526 | SCV000252221 | benign | not provided | 2021-02-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000676526 | SCV002385203 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003967522 | SCV004786228 | likely benign | SARS2-related condition | 2019-02-20 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Mayo Clinic Laboratories, |
RCV000676526 | SCV000802311 | uncertain significance | not provided | 2016-03-02 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001795321 | SCV002033931 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000676526 | SCV002037814 | likely benign | not provided | no assertion criteria provided | clinical testing |